Creating a center to advance biomaterials for health improvements
Humanity Unlocking Biomaterials (HUB) Coordinating Center
This study is all about creating a special center to help scientists work together and develop new materials that can treat different diseases, making it easier to turn their ideas into real treatments for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Chicago NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project ID | NIH-11249891 on NIH RePORTER |
What this research studies
This research aims to establish the Humanity Unlocking Biomaterials (HUB) Coordinating Center to enhance the development and clinical application of biomaterials that can address various diseases. By fostering collaboration among researchers and providing resources, the HUB will help overcome barriers to translating biomaterial technologies into clinical use. The project will involve organizing annual meetings, facilitating virtual collaborations, and promoting innovative approaches like computational modeling to accelerate the commercialization of these technologies.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients suffering from conditions that could benefit from innovative biomaterials, such as cancers and cardiovascular diseases.
Not a fit: Patients with conditions that do not involve biomaterials or those who are not eligible for clinical trials may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of advanced biomaterials that significantly improve treatment options for various diseases.
How similar studies have performed: Previous research has shown promise in advancing biomaterials through collaborative networks, indicating that this approach could be effective.
Where this research is happening
Chicago, UNITED STATES
- University of Illinois at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Eniola-Adefeso, Omolola — University of Illinois at Chicago
- Study coordinator: Eniola-Adefeso, Omolola
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.